Fig. 7
From: MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30
In vivo antitumor efficacy of MF-094@NPs. A Representative fluorescence (MF-094@NPs) and B bioluminescence (SCC4 cells) imaging of SCC4 cell subcutaneous injection-induced xenograft tumor model after intravenous MF-094 or MF-094@NPs injection (1 mg/kg/day). C Sample images of tumor among mice bearing SCC4 cells with different treatments. Tumor volume D and weight E. F TUNEL-positive cells were analyzed in different groups (scale bars: 100 μm). G Xenograft mouse tumors showing c-Myc, GLS1, and SLC1A5 expression. ***P < 0.001